Prot# MCB 0501 INT: Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (aged 12 to 17 years) With Psoriasis Vulgaris

Project: Research project

StatusFinished
Effective start/end date5/28/095/28/15

Funding

  • Health Decisions Inc. (MCB 0501 INT)
  • LEO Pharma A/S (MCB 0501 INT)